Skin Care Spotlight: Alastin

If you’ve spent any time in a dermatologist’s office, medical spa, or even subreddits where people passionately debate peptides, you’ve probably heard of the skin care brand Alastin. This brand has quickly become one of the biggest players in medical-grade skincare and is a fan-favorite for aesthetic injectors, cosmetic surgeons, and serious skin care gurus alike. But how did it get so big, so fast? And what actually makes Alastin products different from the sea of serums and creams out there?

Let’s dive into the story, the science, and the standout products that made Alastin the powerhouse it is today.

Alastin Skincare was founded in 2015 with a focus on developing products that support the skin’s natural ability to regenerate and repair itself, particularly after professional skin treatments like lasers, injectables, microneedling, chemical peels, and even surgery. The brand has since built its identity around proven, clinical-grade formulations that are specifically designed to work with the skin’s natural repair and renewal processes. 

This unique focus on post-procedure skin care nearly instantly put Alastin products on the radar of dermatologists and plastic surgeons who had been searching for research-backed post-procedure products for years.

Alastin Skincare was launched in 2015 by Scott L. Glenn and Justin Hai. In addition, the brand’s science and medical credibility has been guided by Dr. Alan Widgerow, a plastic surgeon and medical researcher whose work helped to shape Alastin’s science-backed formulations. Additionally, veteran formulation chemist John Garruto now serves as Alastin’s Senior Director of Research & Development. His expertise in peptide technology, wound-healing science, and skin-barrier repair have heavily influenced the brand’s signature approach.

Alastin’s mission has always been to combine rigorous medical science, especially knowledge of skin healing and tissue regeneration, with everyday skin care. The founders aimed to design products that support the skin’s structural matrix, enhance healing post-procedure, and rebuild collagen in a way that is consistent with how skin regenerates naturally.

This scientific, research-first philosophy deeply influenced how the brand evolved. From the start, Alastin caught the eye of dermatologists and plastic surgeons, propelling it from start-up to major brand within a few years.

Alastin has earned its reputation by focusing on regenerative skin science, formulating products that work within the extracellular matrix (ECM) – the network of collagen, elastin, and structural proteins that give skin its firmness, bounce, and ability to repair itself.

The brand is best known for these four things:

1. Collagen and elastin remodeling. Most anti-aging brands focus primarily on increasing collagen. Alastin stands out for using Tri Hex peptide technology to "clean out" old damaged collagen and elastin from the skin leaving room for new regenerative structural proteins to form. This helps strengthen the structural support of the dermis (3).
2. Production of High Molecular Weight Hyaluronic Acid (HA) - Increasing skin's ability to make long chain HA has a rejuvenating and plumping effect on the skin.
3. Speed healing and clearing of bruises- Lactoferrin and Tri Hex technology help increase production of the ECM including collagen and help remove hemosiderin from skin to speed healing.

Alastin’s formulas are built around regenerative skin science, with a strong emphasis on how the extracellular matrix (ECM) repairs itself. The ECM is the structural framework of the skin, made of collagen, elastin, fibrillin, hyaluronic acid, and other proteins. When this matrix becomes damaged, through aging, sun exposure, inflammation, or cosmetic procedure, the skin loses firmness and elasticity. Alastin’s technologies are designed to target this problem.

• TriHex Technology® (Peptide Remodeling Complex). This is Alastin’s signature, patented blend of signal peptides that work on two key phases of ECM repair: 1) clearing damaged matrix proteins like collagen and elastin and 2) stimulating new, functional ECM components like collagen types I and II, elastin, and fibrillin, a structural protein essential for elastic fiber formation (4).
• Octapeptide-45 - functions as a powerful anti-aging messenger by specifically upregulating the enzyme Hyaluronan Synthase-2 (HAS2) within dermal fibroblasts. This targeted activation triggers the skin to synthesize its own High Molecular Weight (HMW) Hyaluronic Acid, typically reaching sizes of around 2 MegaDaltons. Unlike the short-chain, low molecular weight HA frequently used in skincare—which can be pro-inflammatory and easily degraded—the HMW HA produced by Octapeptide-45 is inherently anti-inflammatory and highly stable. By fostering a calm, hydrated environment and reinforcing the structural integrity of the extracellular matrix, this peptide effectively plumps the skin from within while reducing the redness and irritation often associated with fragmented hyaluronic acid.
• Lactoferrin- An iron-binding glycoprotein that accelerates post-procedure recovery by sequestering free iron to speed the clearance of red blood cells and hemosiderin. This process significantly shortens the duration of visible bruising and discoloration. Simultaneously, it acts as a potent immunomodulator, calming pro-inflammatory cytokines that trigger collagen breakdown.
• Peptides- Beyond TriHex, Alastin uses additional tetrapeptides, hexapeptides, and biomimetic peptides that reduce inflammatory cytokines, support keratinocyte migration during wound healing, and enhance fibroblast activity to promote collagen and elastin.
• Antioxidants -  Neutralize reactive oxygen species (ROS) that break down ECM proteins, and ceramides, cholesterol, and fatty acids to repair the barrier and support post-procedure healing.

There is a growing body of published clinical data to support Alastin’s claims about its skin care formulations, including biopsy-confirmed evidence of collagen and elastin regeneration. 

Several key studies highlight Alastin’s impact on the skin’s extracellular matrix:

A 2025 multicenter clinical trial on the updated Restorative Skin Complex Serum 2.0 found measurable increases in new, functional collagen and elastin fibers after 12 weeks of twice-daily use. Skin biopsies showed denser, more organized elastic fibers and increased fibrillin, a protein essential for elastic fiber formation. These structural changes correlated with visible improvements in firmness, elasticity, and fine lines (3).

A 2020 study examined Regenerating Skin Nectar and TransFORM Body Treatment in patients undergoing laser or body-contouring procedures. Biopsies demonstrated faster clearance of damaged elastin (elastosis) and an increased expression of genes associated with elastogenesis and collagen synthesis. Patients using Alastin products recovered faster, showed reduced inflammation, and achieved better procedural outcomes compared with controls (5).

Additional published research has shown upregulation of anti-aging genes such as FOXO3 and Klotho, reductions in oxidative stress markers, and improvements in markers associated with dermal thickness and ECM integrity (6).

While Alastin’s clinical data is compelling, it does come with a few notable limitations, as with much skin care research. Several of the published studies were funded by the brand or its parent company, which can introduce bias even when results are objectively measured through biopsies or gene-expression analysis. Some of the human trials also involve small sample sizes, which can make it difficult to generalize the findings to broader populations.

In addition, much of the strongest evidence for collagen and elastin regeneration comes from post-procedure settings, where the skin is already in an active repair state, so results may not be as dramatic when the products are used on untreated skin alone. 

These limitations don’t discount the scientific value, but they do highlight the need to interpret outcomes with realistic expectations and an understanding of the research context.

Alastin products are formulated to be widely compatible with most skin types because their primary focus of ECM repair and inflammation control is relevant to nearly everyone. However, certain skin types in particular may benefit the most from Alastin products:

• Aging or mature skin. Anyone with a “W” for wrinkle-prone in their Baumann Skin Type can benefit from many Alastin products to help with skin laxity, fine lines, or thinning skin.

• Post-procedure skin. Most people undergoing laser resurfacing, microneedling, chemical peels, RF treatments, injectables, or surgery can benefit from the wound-healing peptides and barrier-repair technologies in Alastin post-procedure products.

• Sensitive or easily irritated skin. People with sensitive skin can benefit from Alastin’s use of anti-inflammatory peptides and antioxidants, which help to calm redness and reduce irritation. By dialing down excess inflammation and supporting the skin barrier, these ingredients make active products easier to tolerate and create a healthier environment for repair.

• Dry or dehydrated skin. Products like the Ultra Nourishing Moisturizer and HydraTint SPF support barrier repair and moisture retention.

Like with any skin care product, it is important to make sure the Alastin product you’re looking at is approved for your skin type. Outside of that, the biggest drawback about Alastin products is the cost. Because Alastin uses patented peptide complexes, clinically-validated ingredients, and extensive testing, its products cost more than typical drugstore skin care.

Alastin earned its reputation by focusing on scientifically-validated skin care aimed at enhancing the skin’s natural regenerative processes. While many brands make big claims about collagen support or “repairing the skin,” Alastin is one of the few that has published research showing actual elastin and collagen regeneration confirmed through biopsies and gene expression studies.

Whether you’re preparing for a cosmetic procedure, looking for long-term anti-aging support, or simply want formulas that work with the skin at a cellular level, Alastin offers some of the most advanced, research-backed options available.

1. Baumann L. Antiaging Ingredients in Ch. 37 of Baumann's Cosmetic Dermatology Ed 3. (McGraw Hill 2022)
2. Baumann, L. Ch. Cosmeceuticals and cosmetic Ingredients (McGraw Hill 2015)
3. Gold M, Boyd C, Mraz D, Robison T, Shafiq F, Widgerow AD. A Multi-Center Clinical Trial to Evaluate the Efficacy of the Next Generation TriHex Technology Antiaging Regimen. J Cosmet Dermatol. 2025 Apr;24(4):e70192. doi: 10.1111/jocd.70192. PMID: 40280771; PMCID: PMC12031659.
4. Antoanella Calame, M. D. A single-center clinical trial to evaluate the efficacy of a tripeptide/hexapeptide antiaging regimen.
5. Claytor B, Casas L, Ziegler M, Widgerow AD, Bell M. Evaluating the Efficacy, Tolerability, and Outcomes of Topical Tripeptide/Hexapeptide Formulations Before and After Liposuction of the Medial Thighs. Aesthet Surg J Open Forum. 2020 Dec 30;3(1):ojaa055. doi: 10.1093/asjof/ojaa055. PMID: 33791675; PMCID: PMC7876984.
6. Widgerow, A. D., Ziegler, M. E., Garruto, J. A., & Bell, M. (2022). Effects of a topical anti-aging formulation on skin aging biomarkers. The Journal of Clinical and Aesthetic Dermatology, 15(8), E53.
7. Wang, J. V., Fabi, S. G., Robinson, D. M., Bajaj, S., Geronemus, R. G., Bell, M., ... & Widgerow, A. D. (2024). Extension Phase of a Multi-Center, Randomized, Blinded Clinical Study Evaluating the Efficacy and Safety of a Novel Topical Product for Facial Dyschromia. Journal of Drugs in Dermatology, 23(1), 1266-1270.
8. Moradi, A., Shafiq, F., Robison, T., Colvan, L., Poehler, J., & Widgerow, A. D. (2024). Multicenter evaluation of a topical antioxidant serum. Journal of cosmetic dermatology, 23(1), 145-153.
9. Jalian, H. R., Burns, A. J., Saedi, N., Robb, C., Geronemus, R. G., Karimi, K., ... & Widgerow, A. D. (2025). Enhancing Outcomes of Procedure Pairing With Next Generation Regenerating Skin Nectar With TriHex+ Technology. Journal of Cosmetic Dermatology, 24(12), e70556.